ZBIO Zenas Bio Sotuvning yalpi rentabelligi

Zenas Bio (ZBIO) korporativ emblemasi va logotipi

Zenas Biopharma Inc (ZBIO) daromadlari immunoterapiyani tijoratlashtirish hamda buyrak va qalqonsimon bez kasalliklarini davolash uchun antitanalarni sotishga asoslangan. Ushbu grafikdagi kompaniyaning yalpi marjasi haqiqiy operatsion rentabellikni ko'rsatadi, 99.80 ko'rsatkichi esa joriy darajani tasdiqlaydi. Foyda davlat jamg'armalari tomonidan innovatsion dori vositalarining xarid qilinishiga bog'liq. Kutilayotgan 3-fazani ma'lumotlari katalizator vazifasini o'taydi, joriy xarajatlar esa bozor tomonidan allaqachon hisobga olingan.

Zenas Biopharma (ZBIO) Yalpi rentabellik: 14.09.2024 - 20.11.2026 davri uchun

Zenas Biopharma Inc (ZBIO) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Fundamental baholash:ZBIO - Zenas Bio
Zenas Corp tomonidan chiqariladigan mahsulotlar

Investorlar Zenas Biopharma Inc (ZBIO) kompaniyasini istiqbolli aktiv deb hisoblaydilar va yalpi foyda marginini bevosita ishlab chiqarish xarajatlari chegirib tashlanganidan keyingi foyda ulushi sifatida baholaydilar, bu esa resurslarni boshqarishning fundamental samaradorligini belgilaydi. Yalpi foyda marginining tebranishlarini tahlil qilish orqali kompaniyaning defensiv aktiv sifatidagi maqomini tasdiqlash mumkin, chunki biotexnologiyalarga bo'lgan barqaror talab makroiqtisodiy risklarni yumshatadi va operatsion rentabellikning barqarorligini ta'minlaydi.

Asosiy raqobatchilar

argenx - Yalpi foyda normasi|Yalpi rentabellik biontech.de|ABIVAX (ABVX) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja ADMA|Yalpi foyda koeffitsiyenti PTGX|Yalpi rentabellik Immunovant Corp IMVT|Yalpi marja Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Yalpi foyda bo'yicha rentabellik|Aurinia Pharmaceuticals Inc. (AUPH) - Yalpi marja|Yalpi foyda bo'yicha rentabellik BCRX|Yalpi foyda marjasi Vera Therapeutics Inc VERA|Yalpi foyda bo'yicha rentabellik DNTH (Dianthus Pharma)|Yalpi foyda bo'yicha sotuv rentabelligi Pharvaris N.V.|AbCellera Biologics Inc - Yalpi foyda bo'yicha rentabellik|Tourmaline Bio (TRML) - Yalpi foyda marjasi|PGEN - Yalpi rentabellik|Yalpi foyda normasi PHAR (Pharming Group NV)|NKTR: Yalpi marja|Upstream Bio Corp - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IMNM|GOSS: Yalpi foyda normasi|Yalpi rentabellik KalVista Pharma (KALV)|SEPN - Yalpi foyda marjasi|Yalpi marja PVLA (pieris.com)|Yalpi marja Savara Pharma SVRA|RIGL: Yalpi foyda bo'yicha rentabellik|ANAB - Yalpi marja|ATXS: Yalpi marja|ENGN - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi foyda bo'yicha rentabellik RAPT|JBIO (Aerovate Therapeutics Inc) - Yalpi foyda koeffitsiyenti|Yalpi marja ACRS|Yalpi foyda bo'yicha rentabellik kyvernatx.com KYTX|Yalpi marja TLSA (Tiziana Life Sciences, Ltd.)|Yalpi marja Cabaletta Bio CABA|VTYX: Yalpi foyda bo'yicha rentabellik|Theratechnologies Inc. (THTX) - Yalpi foyda bo'yicha rentabellik|AVTX: Yalpi marja|ELDN - Yalpi foyda bo'yicha sotuv rentabelligi|AGEN (Agenus, Inc) - Yalpi marja|Yalpi marja Climb Bio, Inc.|Yalpi rentabellik Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Yalpi foyda normasi|Yalpi marja ADAG (Adagene Inc)|IMA - Yalpi foyda bo'yicha rentabellik|STTK - Yalpi rentabellik|EQ (equilliumbio.com) - Sotuvning yalpi rentabelligi|CNTB: Yalpi marja|Immunic Inc (IMUX) - Yalpi marja|ATRA (Atara Biotherapeutics Inc) - Yalpi marja|Sotuvning yalpi rentabelligi IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Yalpi foyda normasi|Adicet Bio, Inc. - Sotuvning yalpi rentabelligi|Celularity Inc - Yalpi foyda bo'yicha rentabellik|Yalpi marja INmune Bio Corporation INMB|Barinthus Biotherapeutics - Yalpi marja|Kezar Life Sciences, Inc. (KZR) - Yalpi foyda bo'yicha rentabellik|SAB Biotherapeutics Inc. (SABS) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Akari Therapeutics plc|Yalpi rentabellik enlivex.com|q32bio.com (QTTB) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja GOVX|Edesa Biotech, Inc. - Sotuvning yalpi rentabelligi|iBio Inc - Yalpi foyda bo'yicha rentabellik|Yalpi marja Carisma Therapeutics CARM|XTLB - Yalpi rentabellik|BOLT (boltbio.com) - Sotuvning yalpi rentabelligi|HCWB: Yalpi marja|Aptevo (APVO) - Yalpi marja|Yalpi rentabellik AIM ImmunoTech|Yalpi foyda bo'yicha rentabellik Aditxt (ADTX)|Yalpi foyda bo'yicha rentabellik GRI (GRI Bio Corporation)|XORTX - Sotuvning yalpi rentabelligi|Yalpi marja HIND (Vyome Holdings Inc.)|Yalpi foyda normasi REVB|Indaptus - Yalpi marja|SCNI (Scinai Immunotherapeutics Ltd.) - Sotuvning yalpi rentabelligi|CALI: Yalpi marja|Affimed NV - Yalpi foyda normasi|Yalpi rentabellik Allakos Inc.|Yalpi marja HOOKIPA Pharma|Yalpi rentabellik IGM Biosciences, Inc. (IGMS)|ITOS - Yalpi foyda marjasi|Yalpi marja OCEA (Ocean Bio)|Yalpi foyda normasi TCBP|THRD - Yalpi rentabellik